RA Capital Management, LLC, 10% Owner at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 50,000 shares at $29.05 ($1.5M) on 2010-02-17, disclosed to the SEC on 2010-02-19.
Open-market sale of $1.5M BSTC by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |